Founding Member of Brain-Machine Interface Firm Joins NeuroOne Medical Board

NeuroOne Medical Technologies Corporation, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, has appointed Vanessa Tolosa to its Scientific Advisory Board.

Tolosa, one of the founding members of Neuralink Corp., a company started by Elon Musk to build a complete Brain-Machine interface, brings specialized expertise that the company believes will help expedite its further development of thin-film electrodes that provide long-term stimulation for treatment of neurological applications, such as epilepsy, Parkinson’s disease, failed back surgery syndrome and other neurological applications that may benefit from high-density thin film electrode technology.
 
“We are pleased to have such a distinguished, highly regarded scientific leader and pioneer as Vanessa on our advisory board,” said Dave Rosa, president and CEO, NeuroOne. “Vanessa has over 10 years of specialized experience developing implantable neural devices. She shares our passion in transitioning these technologies from the bench top and bringing them to patients who are in desperate need. Her exceptional experience in this field will contribute greatly to NeuroOne’s vision, goals and future direction.”
 
Most recently at Neuralink, Tolosa worked to develop a Brain-Machine interface for medical use and beyond. As director of neural interfaces, she directed the design, prototyping, development and testing of technologies related to implantable microelectrodes, electronics micro-assembly and hermetic packaging. Previously, at Lawrence Livermore National Laboratories (LLNL), Tolosa led all implantable neurotechnology efforts, including high-density electrode technology.
 
Among her credits, Tolosa won the 2019 Gold Electrode Researcher of the Year Award from Neurotech Reports, the 2015 LLNL Early-Mid Career Researcher Award and the 2015 DARPA Riser Award. She holds eight issued patents with five pending applications in this field.

Tolosa earned a bachelor of science degree in chemical engineering from the University of Florida and a Ph.D. in chemical engineering from the University of California, Los Angeles.
 
Tolosa stated, “NeuroOne is bringing unique thin-film electrodes to the marketplace, and I look forward to helping them refine their implantable neural technology that addresses chronic treatments, as well as making enhancements to its FDA-cleared Evo cortical electrode line.”